159 related articles for article (PubMed ID: 32820148)
21. miR-3928 activates ATR pathway by targeting Dicer.
Chang L; Hu W; Ye C; Yao B; Song L; Wu X; Ding N; Wang J; Zhou G
RNA Biol; 2012 Oct; 9(10):1247-54. PubMed ID: 22922797
[TBL] [Abstract][Full Text] [Related]
22. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs.
Su X; Chakravarti D; Cho MS; Liu L; Gi YJ; Lin YL; Leung ML; El-Naggar A; Creighton CJ; Suraokar MB; Wistuba I; Flores ER
Nature; 2010 Oct; 467(7318):986-90. PubMed ID: 20962848
[TBL] [Abstract][Full Text] [Related]
23. microRNA-485-5p inhibits the progression of hepatocellular carcinoma through blocking the WBP2/Wnt signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Signal; 2020 Feb; 66():109466. PubMed ID: 31706018
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of low DICER expression regulated by miR-130a in cervical cancer.
He L; Wang HY; Zhang L; Huang L; Li JD; Xiong Y; Zhang MY; Jia WH; Yun JP; Luo RZ; Zheng M
Cell Death Dis; 2014 May; 5(5):e1205. PubMed ID: 24787017
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation of E-box binding USF-1 by PI3K/AKT enhances its transcriptional activation of the WBP2 oncogene in breast cancer cells.
Ramos A; Miow QH; Liang X; Lin QS; Putti TC; Lim YP
FASEB J; 2018 Sep; ():fj201801167RR. PubMed ID: 30183375
[TBL] [Abstract][Full Text] [Related]
26. Elevated WBP2 Expression in HER2-positive Breast Cancers Correlates with Sensitivity to Trastuzumab-based Neoadjuvant Therapy: A Retrospective and Multicentric Study.
Kang SA; Guan JS; Tan HJ; Chu T; Thike AA; Bernadó C; Arribas J; Wong CY; Tan PH; Gudi M; Putti TC; Sohn J; Lim SH; Lee SC; Lim YP
Clin Cancer Res; 2019 Apr; 25(8):2588-2600. PubMed ID: 30593516
[TBL] [Abstract][Full Text] [Related]
27. WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple-negative breast cancer via NF-κB activation.
Lim YX; Lin H; Chu T; Lim YP
Mol Oncol; 2022 Jan; 16(2):422-446. PubMed ID: 34197030
[TBL] [Abstract][Full Text] [Related]
28. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the Hippo signaling pathway.
Nandy SB; Arumugam A; Subramani R; Pedroza D; Hernandez K; Saltzstein E; Lakshmanaswamy R
Oncotarget; 2015 Jul; 6(19):17366-78. PubMed ID: 25962054
[TBL] [Abstract][Full Text] [Related]
30. DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer.
Wang D; Li Z; Li X; Yan C; Yang H; Zhuang T; Wang X; Zang Y; Liu Z; Wang T; Jiang R; Su P; Zhu J; Ding Y
J Exp Clin Cancer Res; 2022 Jul; 41(1):219. PubMed ID: 35820928
[TBL] [Abstract][Full Text] [Related]
31. Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling.
Hergovich A; Hemmings BA
Biofactors; 2009; 35(4):338-45. PubMed ID: 19484742
[TBL] [Abstract][Full Text] [Related]
32. KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals.
Moleirinho S; Chang N; Sims AH; Tilston-Lünel AM; Angus L; Steele A; Boswell V; Barnett SC; Ormandy C; Faratian D; Gunn-Moore FJ; Reynolds PA
Oncogene; 2013 Apr; 32(14):1821-30. PubMed ID: 22614006
[TBL] [Abstract][Full Text] [Related]
33. Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer.
Mori M; Triboulet R; Mohseni M; Schlegelmilch K; Shrestha K; Camargo FD; Gregory RI
Cell; 2014 Feb; 156(5):893-906. PubMed ID: 24581491
[TBL] [Abstract][Full Text] [Related]
34. MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation.
Suzuki HI; Arase M; Matsuyama H; Choi YL; Ueno T; Mano H; Sugimoto K; Miyazono K
Mol Cell; 2011 Nov; 44(3):424-36. PubMed ID: 22055188
[TBL] [Abstract][Full Text] [Related]
35. Tyrosine phosphorylation of transcriptional coactivator WW-domain binding protein 2 regulates estrogen receptor α function in breast cancer via the Wnt pathway.
Lim SK; Orhant-Prioux M; Toy W; Tan KY; Lim YP
FASEB J; 2011 Sep; 25(9):3004-18. PubMed ID: 21642474
[TBL] [Abstract][Full Text] [Related]
36. Loss of MST/Hippo Signaling in a Genetically Engineered Mouse Model of Fusion-Positive Rhabdomyosarcoma Accelerates Tumorigenesis.
Oristian KM; Crose LES; Kuprasertkul N; Bentley RC; Lin YT; Williams N; Kirsch DG; Linardic CM
Cancer Res; 2018 Oct; 78(19):5513-5520. PubMed ID: 30093562
[TBL] [Abstract][Full Text] [Related]
37. LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5.
Jacob J; Favicchio R; Karimian N; Mehrabi M; Harding V; Castellano L; Stebbing J; Giamas G
Cancer Lett; 2016 Mar; 372(1):137-46. PubMed ID: 26739063
[TBL] [Abstract][Full Text] [Related]
38. DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1.
Sun X; Tang SC; Xu C; Wang C; Qin S; Du N; Liu J; Zhang Y; Li X; Luo G; Zhou J; Xu F; Ren H
J Cell Mol Med; 2015 Jun; 19(6):1357-65. PubMed ID: 25702703
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
40. PAK5 promotes RNA helicase DDX5 sumoylation and miRNA-10b processing in a kinase-dependent manner in breast cancer.
Li Y; Xing Y; Wang X; Hu B; Zhao X; Zhang H; Han F; Geng N; Wang F; Li Y; Li J; Jin F; Li F
Cell Rep; 2021 Dec; 37(12):110127. PubMed ID: 34936874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
